2007
DOI: 10.1016/j.survophthal.2006.10.006
|View full text |Cite
|
Sign up to set email alerts
|

Ophthalmic Manifestations and Histopathology of Infantile Nephropathic Cystinosis: Report of a Case and Review of the Literature

Abstract: Cystinosis is a rare autosomal recessive metabolic disorder characterized by the intracellular accumulation of cystine, the disulfide of the amino acid cysteine, in many organs and tissues. Infantile nephropathic cystinosis is the most severe phenotype. Corneal crystal accumulation and pigmentary retinopathy were originally the most commonly described ophthalmic manifestations, but successful kidney transplantation significantly changed the natural history of the disease. As cystinosis patients now live longer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
75
0
3

Year Published

2007
2007
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 84 publications
(80 citation statements)
references
References 90 publications
(52 reference statements)
2
75
0
3
Order By: Relevance
“…The most commonly encountered ocular symptoms of corneal cystinosis include photophobia, foreign body sensation and pain 3 4. In our study, 18 (56%) patients had photophobia at presentation.…”
Section: Discussionmentioning
confidence: 48%
See 2 more Smart Citations
“…The most commonly encountered ocular symptoms of corneal cystinosis include photophobia, foreign body sensation and pain 3 4. In our study, 18 (56%) patients had photophobia at presentation.…”
Section: Discussionmentioning
confidence: 48%
“…Nephropathic cystinosis is divided into infantile (classic) and intermediate (juvenile-onset or adolescent) types. Non-nephropathic cystinosis was formerly called benign or adult type cystinosis but is now termed ocular cystinosis 3. Nephropathic or classic infantile cystinosis is the most severe phenotype.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…This cystine-depleting drug is therapeutically important in the treatment of cystinosis, a rare autosomal recessive metabolic disorder caused by mutations of the lysosomal cystine carrier cystinosin encoded by the CTNS gene, responsible for cystine exodus from the lysosomes [6]. As a result of deficient or absent cystine transporter, the disulfide amino acid accumulates within lysosomes and crystallizes in many tissues and organs, including the kidney and nervous system [7,8]. In the most common type of cystinosis, nephropathic or infantile cystinosis, renal tubular Fanconi syndrome occurs at 6-12 months of age and progresses, if untreated, to terminal renal failure before the age of 10 [9].…”
Section: Introductionmentioning
confidence: 99%
“…The pathognomonic ocular manifestation of cystinosis is the deposition of distinctive iridescent crystals in the cornea. 22 Ocular symptoms include glare, photophobia, decreased corneal sensation, and mild decrease in vision.…”
mentioning
confidence: 99%